94 related articles for article (PubMed ID: 327638)
1. Chimerism in humans.
Gill TJ
Transplant Proc; 1977 Jun; 9(2):1423-31. PubMed ID: 327638
[No Abstract] [Full Text] [Related]
2. Chimerism and mosaicism--two different entities.
Benirschke K
Obstet Gynecol Annu; 1974; 3(0):33-45. PubMed ID: 4608081
[No Abstract] [Full Text] [Related]
3. Blood group mosaics.
Race RR; Sanger R
Haematologia (Budap); 1972; 6(1):63-71. PubMed ID: 4554674
[No Abstract] [Full Text] [Related]
4. [Patients with chimerism--immunologic detection of bone marrow acceptance].
Májský A; Korínková P; Herzog P; Chudomel V
Z Gesamte Inn Med; 1988 May; 43(9):247-9. PubMed ID: 3043943
[TBL] [Abstract][Full Text] [Related]
5. Maternal modification of antigenicity: an immunologic mechanism to ensure survival of mammalian fetuses.
Uphoff DE
J Natl Cancer Inst; 1970 Dec; 45(6):1189-96. PubMed ID: 4922674
[No Abstract] [Full Text] [Related]
6. [Diagnosis of chimerism based on blood group determination].
Seyfriedowa H; Kuśnierz G; Górska B; Fedyk T
Acta Haematol Pol; 1975; 6(2):105-12. PubMed ID: 1154987
[TBL] [Abstract][Full Text] [Related]
7. Immunologic chimerism as evidence of bone marrow graft acceptance in an identical twin with acute lymphocytic leukemia.
Starling KA; Falletta JM; Fernbach DJ
Exp Hematol; 1975 Aug; 3(4):244-8. PubMed ID: 1100419
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte depletion in the induction of chimerism in mice.
Deaton JG
J Reticuloendothel Soc; 1973 Feb; 13(2):161-5. PubMed ID: 4145188
[No Abstract] [Full Text] [Related]
9. Mixtures, mosaics and modifications.
Bird GW
Rev Fr Transfus Immunohematol; 1976 Mar; 19(1):247-52. PubMed ID: 788107
[No Abstract] [Full Text] [Related]
10. Fetal immune suppression as adjunctive therapy for in utero hematopoietic stem cell transplantation in nonhuman primates.
Shields LE; Gaur L; Delio P; Potter J; Sieverkropp A; Andrews RG
Stem Cells; 2004; 22(5):759-69. PubMed ID: 15342940
[TBL] [Abstract][Full Text] [Related]
11. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
[No Abstract] [Full Text] [Related]
12. [Chimerism pattern following allogeneic bone marrow transplantation; a retrospective study of the connection with post-transplantation complications].
Vlieger AM; Richel DJ; Zwaan FE; Beverstock GC; Willemze R; Fibbe WE
Ned Tijdschr Geneeskd; 1990 May; 134(18):908-13. PubMed ID: 2345579
[TBL] [Abstract][Full Text] [Related]
13. Chimerism following fetal transfusion. Report of leucocyte hybridization and infant with acute lymphocytic leukaemia.
Turner JH; Hutchinson DL; Petricciani JC
Scand J Haematol; 1973; 10(5):358-66. PubMed ID: 4203767
[No Abstract] [Full Text] [Related]
14. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes.
Hayashi S; Hsieh M; Peranteau WH; Ashizuka S; Flake AW
Exp Hematol; 2004 Mar; 32(3):290-9. PubMed ID: 15003315
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
Rowley SD; Liang PS; Ulz L
Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
[TBL] [Abstract][Full Text] [Related]
16. Unrelated donors for bone-marrow transplantation and transfusion support: pool sizes required.
Opelz G; Mickey MR; Terasaki PI
Transplant Proc; 1974 Dec; 6(4):405-9. PubMed ID: 4280165
[No Abstract] [Full Text] [Related]
17. Immunological considerations of bone marrow transplantation.
Uphoff DE
Transplant Proc; 1969 Mar; 1(1):39-43. PubMed ID: 4944248
[No Abstract] [Full Text] [Related]
18. Bone marrow transplantation for severe combined immune deficiency in an infant with chimerism due to intrauterine-derived maternal lymphocytes: donor engraftment documented by chromosomal marker studies.
Borzy MS; Magenis E; Tomar D
Am J Med Genet; 1984 Jul; 18(3):527-39. PubMed ID: 6383041
[TBL] [Abstract][Full Text] [Related]
19. Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.
Cotteret S; Belloc F; Boiron JM; Bilhou-Nabera C; Dumain P; Boyer C; Lacombe F; Reiffers J; Bernard P
Cytometry; 1998 Oct; 34(5):216-22. PubMed ID: 9822307
[TBL] [Abstract][Full Text] [Related]
20. Lymphopoietic potential of bone marrow cells from aged mice: comparison of the cellular constituents of bone marrow from young and aged mice.
Farrar JJ; Loughman BE; Nordin AA
J Immunol; 1974 Mar; 112(3):1244-9. PubMed ID: 4590703
[No Abstract] [Full Text] [Related]
[Next] [New Search]
